References
- Dally P. J. Fatal reaction associated with tranylcypromine and M-amphetamine. Lancet 1962; i: 1235–1236
- Everett G. M., Wiegand R. G., Rinaldi F. V. Pharmacologic studies of some non-hydrazine MAO inhibitors. Ann. N. Y. Acad. Sci 1963; 107: 1068–1080
- Grinspoon L., Hedblom M. A. Amphetamine abuse. Drug Ther January, 1972; 83–93
- Jefferson J. W. Beta-adrenergic receptor blocking drugs in psychiatry. Arch. Gen. Psychiatry 1974; 31: 681–691
- MacDonald R. Tranylcypromine. Lancet 1963; i: 269
- Maletzky B. M. Assisted covert sensitization for drug abuse. Int. J. Addict 1974a; 9: 411–429
- Maletzky B. M. Assisted covert sensitization in the treatment of exhibitionism. J. Consult. Clin. Psychol 1974b; 42: 34–40
- Maletzky B. M., George F. S. The treatment of homosexuality by “assisted” covert sensitization. Behav. Res. Ther 1973; 11: 655–657
- Mason A. Fatal reaction associated with tranylcypromine and M-amphetamine. Lancet 1962; i: 1073
- Meyler L. Side Effects of Drugs: Adverse Reactions as Reported in the Medical Literature of the World 1963–1965. Excepta Medica Foundation, New York 1966; Vol. 5: 16–25
- Nymark M., Nielson J. M. Reactions due to the combination of MAO inhibitors with thymoleptics. pethidine, or M-amphetamine. Lancet 1963; ii: 524–525
- Physicians' Desk Reference. Medical Economics Company, Oradell, New Jersey 1975; 1389, 1571
- Sargant W. Combining the antidepressant drugs. Lancet 1963; ii: 634–635
- Sjogvist F. Psychotropic drugs (2); Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc. R. Soc. Med 1965; 58: 967–978
- Stockley I. H. Monoamine oxidase inhibitors: Part 1: Interactions with sympathomi-metric amines. Pharm. J June 30, 1973; 590–593
- Vankammen D. P., Murphy D. L. Blockading of d- and l-amphetamine-induced activation and euphoria by lithium carbonate. J. Pharmacol 1974; 5(suppl. 2)102
- Zeck P. Dangers of some antidepressant drugs. Med. J. Aust 1961; 2: 607–608